e-ISSN: 2394-2967
logo

British Journal of Medical and Health Research

LoginTrack

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

Volume 4, Issue 8 - 2017 (August 2017 Issue 8)

Volume 4 Issue 8 Cover

Issue Details:

Volume 4 Issue 8
Published:Invalid Date

Editorial: August 2017 Issue 8

Welcome to the 2017 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Hemangi J Patel
Editor-in-Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 4 of 4 articles
Research PaperID: BJMHR0408001

ETIOLOGY, TREATMENT AND PREVENTION OF IRON DEFICIENCY ANAEMIA (IDA) IN WOMEN : A REVIEW

Ghulam Nabi Bader, Amreen Naqash, Rifat Ara

Iron deficiency anaemia (IDA) is a significant problem worldwide. It is widespread and a most neglected nutritional deficiency especially in the developing countries. The IDA can be evaluated by low hemoglobin and iron stores value. Women among all age group, particularly during pregnancy, and children should be screened for IDA. In adults, IDA can result in reduced work capacity, immune dysfunction, impaired thermoregulation, Gastrointestinal (GI) disturbances while in children or adolescents it can impact motor and mental development. IDA can be treated both by oral and parenteral therapy. In this review etiology, treatment, and prevention of iron deficiency anaemia are discussed.

Iron deficiency anaemia (IDA)hemoglobiniron storesoral therapyparenteral therapy.
25,809 views
7,651 downloads

Contributors:

 Ghulam Nabi Bader
,
 Amreen Naqash
,
 Rifat Ara
Research PaperID: BJMHR0408002

Role of Cytokines in Psoriasis

Poosarla Aparanji

Abstract Psoriasis is a common inflammatory skin disease with an incompletely understood etiology. The disease is characterized by red, scaly and well-demarcated skin lesions formed by the hyperproliferation of epidermal keratinocytes. This hyperproliferation is driven by cytokines secreted by activated resident immune cells, an infiltrate of T cells, dendritic cells and cells of the innate immune system, as well as the keratinocytes themselves. Psoriasis has a strong hereditary character and has a complex genetic background. Genome-wide association studies have identified polymorphisms within or near a number of genes encoding cytokines, cytokine receptors or elements of their signal transduction pathways, further implicating these cytokines in the psoriasis path mechanism. A considerable number of inflammatory cytokines have been shown to be elevated in lesional psoriasis skin, and the serum concentrations of a subset of these also correlate with psoriasis disease severity. The combined effects of the cytokines found in psoriasis lesions likely explain most of the clinical features of psoriasis, such as the hyperproliferation of keratinocytes, increased neovascularization and skin inflammation. Thus, understanding which cytokines play a pivotal role in the disease process can suggest potential therapeutic targets. A number of cytokines have been therapeutically targeted with success, revolutionizing treatment of this disease. Here we review a number of key cytokines implicated in the pathogenesis of psoriasis.

PsoriasisSkinInflammationCytokines
25,690 views
7,686 downloads

Contributors:

 Poosarla Aparanji
Research PaperID: BJMHR0408003

Metastatic Tubal Dysgerminoma: A rare case report

Utpal Dutta, Mondita Borgohain, Jayanta Kr. Das

Background: Dysgerminomas are the most common of the primitive germ cell tumours. They account for nearly half of such tumours, 1% of all ovarian cancers. About 10% of these tumours are grossly bilateral. Though rare, dysgerminoma can metastasize to fallopian tube. Case Report: A 20 year old female presented to the gynaecology OPD with complain of abdominal swelling, was found to have bilateral abdomino-pelvic lump. On CT-Scan heterogeneously enhancing solid SOL was noted in abdomino-pelvic cavity. During operation bilateral ovarian mass with lymphadenopathy was seen and resected mass was sent for histopathological examination. Microscopically both the ovaries showed the picture of Dysgerminoma with involvement of the left tube. Conclusion: This case of dysgerminoma with tubal metastasis has been reported in view of its rarity. However, diagnosis of these tumours should only be given after proper extensive sectioning to rule out any other germ cell component.

Germ cell tumoursDysgerminomatubal metastasis
26,059 views
7,774 downloads

Contributors:

 Utpal Dutta
,
 Mondita Borgohain
,
 Jayanta Kr. Das
Research PaperID: BJMHR0408004

Supratentorial Recurrent Glioma, Presentation and Outcome Clinical Study

Dr. Amar Saeed Rashid Hejaju, Dr. Akeel Muslim Kadhim Alakaishy, Dr. Hussain Sahib Hussain AL-Yaqoobi

ABSTRACT: Gliomas are the most frequent primary brain tumors. Most gliomas require aggressive combination of therapy with radiotherapy and chemotherapy after maximal surgery. Recurrent glioma is a significant deterioration in an existing neurological deficit. The current study aimed to prospectively assess the clinical characteristics of first and second presentations of patients, the optimal treatment among the available modalities for recurrent glioma and to illustrate the highly selected individuals with recurrent glioma and the determinants of treatment modalities and patients recruited for. Hence a prospective study on 24 patients with recurrent cerebral glioma carried out in the Neurosurgical Teaching Hospital in Baghdad/Capital of Iraq during Feb. 2009 to Feb. 2011. Twenty one patients (87.5%) were exposed to second operation directed at their tumor site, and had mean survival of 50 weeks, while 3 patients (12.5%) had been treated by chemotherapy had survived for a mean of 11 weeks. Reoperation was associated with a mortality rate of (4.1%). Best survival and good outcome was found in those who had good neurological performance and they were relatively young age. Malignant transformation and dedifferentiation was found in (75%) of cases. In conclusion, no curable treatment regarding recurrent glioma is definite, but reoperation is feasible and can be carried with less morbidity and mortality when considering a good selection criteria of the patients, preserving chemotherapy for those who are not amenable for surgery.

Supratentorial GliomaRecurrentpathologyManagementmortality.
26,137 views
7,817 downloads

Contributors:

 Dr. Amar Saeed Rashid Hejaju
,
 Dr. Akeel Muslim Kadhim Alakaishy
,
 Dr. Hussain Sahib Hussain AL-Yaqoobi

Related Issues

Volume 13, Issue 1

2026 • 2 articles

Volume 12, Issue 12

2025 • 2 articles

Volume 12, Issue 11

2025 • 2 articles

Volume 12, Issue 10

2025 • 2 articles